• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚多卡醇硬化治疗对口腔血管畸形的疗效

Therapeutic Effect of Polidocanol Sclerotherapy on Oral Vascular Malformations.

作者信息

Fukuzawa Satoshi, Yamagata Kenji, Okubo-Sato Makiko, Terada Kazuhiro, Uchida Fumihiko, Ishibashi-Kanno Naomi, Bukawa Hiroki

机构信息

Department of Oral and Maxillofacial Surgery, Institute of Clinical Medicine, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8575, Ibaraki, Japan.

出版信息

Dent J (Basel). 2021 Oct 14;9(10):119. doi: 10.3390/dj9100119.

DOI:10.3390/dj9100119
PMID:34677181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8534538/
Abstract

Various treatments for oral vascular malformation (VM) have been reported. Polidocanol and absolute ethanol have also been reported for sclerotherapy. However, there are still few reports on the therapeutic effect and dosage of polidocanol sclerotherapy. Therefore, we examined its therapeutic effects on oral VM. There were 17 sites of VMs, with nine patients diagnosed with oral VM at the Department of Dental and Oral Surgery, Tsukuba University Hospital. The medical records were retrospectively investigated to determine the site, hemangioma volume, polidocanol injection volume, and therapeutic effect. The volume of hemangiomas was calculated using magnetic resonance images. Based on the site, oral VMs were observed in the tongue, buccal mucosa, lips, and oral floor in eight, three, five, and one patients, respectively. The average size of the site was 3071 mm. The average injection dose of polidocanol at one site was 2.86 mL, the average number of administrations was 1.6, and the response rate was 88.2%. No adverse events were observed. The median numerical rating scale scores were 2/10 (0-6/10) and 0/10 (0-1/10) the day after surgery and 1 week after surgery, respectively. Univariate regression analysis of the total dose in successful cases provided the following formula: 1.3 + 0.00025 × volume (mm) (mg). Polidocanol sclerotherapy is an effective treatment method for oral VM.

摘要

已有多种治疗口腔血管畸形(VM)的方法被报道。聚多卡醇和无水乙醇也被用于硬化治疗。然而,关于聚多卡醇硬化治疗的疗效和剂量的报道仍然很少。因此,我们研究了其对口腔VM的治疗效果。共有17个VM部位,9例患者在筑波大学医院口腔颌面外科被诊断为口腔VM。对病历进行回顾性研究,以确定病变部位、血管瘤体积、聚多卡醇注射量和治疗效果。血管瘤体积通过磁共振成像计算。根据病变部位,分别在8例、3例、5例和1例患者的舌、颊黏膜、唇和口底观察到口腔VM。病变部位的平均大小为3071立方毫米。一个部位聚多卡醇的平均注射剂量为2.86毫升,平均给药次数为1.6次,有效率为88.2%。未观察到不良事件。术后第1天和术后1周的数字评定量表评分中位数分别为2/10(0 - 6/10)和0/10(0 - 1/10)。对成功病例的总剂量进行单因素回归分析得到以下公式:1.3 + 0.00025×体积(立方毫米)(毫克)。聚多卡醇硬化治疗是一种治疗口腔VM的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b262/8534538/584c842ce6ab/dentistry-09-00119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b262/8534538/4043c7927987/dentistry-09-00119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b262/8534538/1a9dbfe6c72d/dentistry-09-00119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b262/8534538/584c842ce6ab/dentistry-09-00119-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b262/8534538/4043c7927987/dentistry-09-00119-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b262/8534538/1a9dbfe6c72d/dentistry-09-00119-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b262/8534538/584c842ce6ab/dentistry-09-00119-g003.jpg

相似文献

1
Therapeutic Effect of Polidocanol Sclerotherapy on Oral Vascular Malformations.聚多卡醇硬化治疗对口腔血管畸形的疗效
Dent J (Basel). 2021 Oct 14;9(10):119. doi: 10.3390/dj9100119.
2
Foam Sclerotherapy in the Treatment of Hemangiomas and Venous Malformations.泡沫硬化疗法治疗血管瘤和静脉畸形。
Dermatol Surg. 2023 Sep 1;49(9):855-861. doi: 10.1097/DSS.0000000000003857. Epub 2023 Jul 10.
3
Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.聚桂醇泡沫硬化剂治疗静脉畸形的高效技术:中期结果。
J Vasc Surg Venous Lymphat Disord. 2020 Nov;8(6):1066-1073. doi: 10.1016/j.jvsv.2019.11.022. Epub 2020 Apr 10.
4
Sclerotherapy of Venous Malformations Using Polidocanol: Effectiveness, Safety, and Predictors of Outcomes and Adverse Events.聚多卡醇硬化治疗静脉畸形:疗效、安全性以及结局和不良事件的预测因素。
J Vasc Interv Radiol. 2023 Dec;34(12):2103-2109. doi: 10.1016/j.jvir.2023.08.032. Epub 2023 Aug 26.
5
Preliminary Experience With More Stable Polidocanol Foam in Sclerotherapy of Head and Neck Venous Malformations.更稳定的聚多卡醇泡沫在头颈部静脉畸形硬化治疗中的初步经验
Dermatol Surg. 2018 Nov;44(11):1421-1426. doi: 10.1097/DSS.0000000000001587.
6
Foam Polidocanol Sclerotherapy for Low-Flow Vascular Malformations of Tongue.泡沫聚多卡醇硬化疗法治疗舌部低流量血管畸形
Ann Maxillofac Surg. 2019 Jul-Dec;9(2):257-260. doi: 10.4103/ams.ams_81_19.
7
Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief.聚多卡醇硬化治疗疼痛性静脉畸形:缓解疼痛的安全性和疗效评价。
Eur Radiol. 2009 Oct;19(10):2474-80. doi: 10.1007/s00330-009-1442-2. Epub 2009 May 14.
8
Clinical outcomes and predictors of bleomycin polidocanol foam sclerotherapy treatment response in venous malformations.静脉畸形博来霉素聚多卡醇泡沫硬化治疗反应的临床结果和预测因素。
J Int Med Res. 2024 Jan;52(1):3000605231223441. doi: 10.1177/03000605231223441.
9
Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations: A meta-analysis.聚多卡醇治疗血管瘤和血管畸形的有效性和安全性:一项荟萃分析。
Dermatol Ther. 2018 Jan;31(1). doi: 10.1111/dth.12568. Epub 2017 Oct 30.
10
Ultrasound-guided polidocanol foam sclerotherapy for treating venous malformations.超声引导下聚多卡醇泡沫硬化疗法治疗静脉畸形
J Clin Ultrasound. 2018 Jan;46(1):23-31. doi: 10.1002/jcu.22546. Epub 2017 Oct 28.

引用本文的文献

1
Experience with 808-nm diode laser in the treatment of 47 cases of oral vascular anomalies.808nm 半导体激光治疗口腔血管畸形 47 例体会。
Braz Oral Res. 2024 Apr 5;38:e025. doi: 10.1590/1807-3107bor-2024.vol38.0025. eCollection 2024.
2
Efficacy of foam sclerotherapy with polidocanol for the management of oral venous malformations.聚多卡醇泡沫硬化疗法治疗口腔静脉畸形的疗效
Med Int (Lond). 2024 Mar 26;4(3):24. doi: 10.3892/mi.2024.148. eCollection 2024 May-Jun.
3
Evaluation of the Effects of Polidocanol Injection in the Treatment of Temporomandibular Joint Hypermobility - A Prospective Study.

本文引用的文献

1
Efficacy and safety of polidocanol in the treatment of varicose veins of lower extremities: A protocol for systematic review and meta-analysis.聚多卡醇治疗下肢静脉曲张的疗效和安全性:系统评价和荟萃分析方案。
Medicine (Baltimore). 2021 Feb 26;100(8):e24500. doi: 10.1097/MD.0000000000024500.
2
Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children - A retrospective cohort study from a single tertiary medical center.超声引导下聚多卡醇经皮硬化治疗儿童静脉畸形——来自单一三级医疗中心的回顾性队列研究
Medicine (Baltimore). 2020 Feb;99(9):e18839. doi: 10.1097/MD.0000000000018839.
3
聚多卡醇注射液治疗颞下颌关节活动度过大的效果评估——一项前瞻性研究
Ann Maxillofac Surg. 2022 Jul-Dec;12(2):166-172. doi: 10.4103/ams.ams_138_22. Epub 2023 Jan 10.
The efficacy of polidocanol sclerotherapy in mucocele of the minor salivary gland.
聚多卡醇硬化疗法治疗小唾液腺黏液囊肿的疗效。
J Oral Pathol Med. 2018 Oct;47(9):895-899. doi: 10.1111/jop.12764. Epub 2018 Jul 28.
4
Polidocanol (Lauromacrogol 400) has anti-angiogenic effects in vitro and in vivo.聚多卡醇(聚乙二醇月桂醚400)在体外和体内均具有抗血管生成作用。
Eur Rev Med Pharmacol Sci. 2016 Apr;20(7):1384-9.
5
Endovascular methods for the treatment of vascular anomalies.血管畸形的血管内治疗方法。
Neuroimaging Clin N Am. 2013 Nov;23(4):703-28. doi: 10.1016/j.nic.2013.03.016. Epub 2013 May 30.
6
Outcomes and complications of sclerotherapy for venous malformations.静脉畸形硬化治疗的结果与并发症
Vasc Endovascular Surg. 2013 Aug;47(6):454-61. doi: 10.1177/1538574413492390. Epub 2013 Jun 11.
7
Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief.聚多卡醇硬化治疗疼痛性静脉畸形:缓解疼痛的安全性和疗效评价。
Eur Radiol. 2009 Oct;19(10):2474-80. doi: 10.1007/s00330-009-1442-2. Epub 2009 May 14.
8
Venous malformations: classification, development, diagnosis, and interventional radiologic management.静脉畸形:分类、发展、诊断及介入放射学管理
Radiol Clin North Am. 2008 May;46(3):545-97, vi. doi: 10.1016/j.rcl.2008.02.008.
9
Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations.超声引导下泡沫硬化疗法与超声引导下液体硬化疗法治疗有症状静脉畸形的前瞻性随机疗效比较
J Vasc Surg. 2008 Mar;47(3):578-84. doi: 10.1016/j.jvs.2007.11.026.
10
Dose- and time-dependent liquid sclerosant effects on endothelial cell death.剂量和时间依赖性液体硬化剂对内皮细胞死亡的影响。
Dermatol Surg. 2006 Dec;32(12):1444-52. doi: 10.1111/j.1524-4725.2006.32350.x.